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Bladder cancer is the eighth most common cancer in Taiwanese men, and the inci-
dence of primary bladder cancer is more common than that of metastatic bladder 
cancer. Metastatic bladder cancers most commonly occur secondary to skin melano-
mas, followed by breast and gastric cancers. Therefore, bladder adenocarcinoma is 
rare and should be considered due to its metastatic origin. Its clinical course is ag-
gressive and the prognosis is bad. We report a case of gastric cancer with bladder 
metastasis in a middle-aged man. We review the literature and discuss the clinical 
course, pathological characteristics, treatment, and prognosis of this disease.
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1.  Introduction
Bladder cancer is the eighth most common cancer in the 
Taiwanese male population.1 Primary bladder urothelial 
carcinoma is the most common type, followed by squa-
mous cell carcinoma and adenocarcinoma. A neoplastic 
metastatic urinary bladder tumor should be considered 
as having another origin such as a melanoma, or breast 
or gastric adenocarcinoma. Primary bladder adenocarci-
noma is uncommon and urachal cancer should be sus-
pected. One of the most common forms of bladder 
adenocarcinoma is metastatic cancer. Therefore, blad-
der adenocarcinoma should be investigated with a high 
index of suspicion as metastatic cancer from a distant 
focus. The clinical course of metastatic adenocarcinoma 
is usually aggressive and the prognosis is always very 
poor. We present a case of gastric cancer with bladder 
metastasis.
2.  Case Report
A 51-year-old man visited our urology department with the 
chief complaint of painless gross hematuria persisting 
for 1 month. The patient had a history of a gastric adeno-
carcinoma with lymph node metastasis (at stage 
T3N2M0) for which he had undergone a subtotal gas-
trectomy 2 years previously (Figure 1A). The patient re-
ported that he had since had regular outpatient follow-up 
visits. Cystoscopy revealed an ulcerative tumor located 
over the bladder dome (Figure 2). Renal ultrasonogra-
phy showed that he had left-sided hydronephrosis. 
Therefore, he was admitted for further evaluation and 
management.
On admission, the patient’s vital signs were stable. A 
urine analysis revealed hematuria (red blood cells > 100/
high-power field). Laboratory results disclosed some ab-
normal findings (hemoglobin was 11.5 g/dL, platelets 
were 159/μL, and creatinine was 1.7 mg/dL). The find-
ings of urine cytology were negative. Abdominal and 
pelvic computed tomographic (CT) (Figure 3) scans re-
vealed a localized tumor arising from the bladder dome. 
A partial cystectomy with en bloc bladder tumor exci-
sion was undertaken. Histological analysis showed that 
the tumor was a poorly differentiated adenocarcinoma. 
This finding was consistent with a history of gastric can-
cer with tumor cells infiltrating all layers of the bladder 
(deep muscle and serosa) except for the urothelial 
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Figure 1 (A) Poorly differentiated gastric adenocarcinoma (hematoxylin and eosin stain; original magnification, 100˜). 
(B) Histologically, the tumor is composed of a metastatic adenocarcinoma (hematoxylin and eosin stain; original magnification, 100˜).
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Figure 2 Cystoscopy shows an ulcerative tumor located over 
the bladder dome.
Figure 3   Abdominal and pelvic computed tomography show 
a localized bladder dome tumor.
Figure 4 Retrograde pyelography shows that obstructive 
hydronephrosis is due to stricture of the left upper ureter.
received serial ureteroscopy stenting and a ureter bi-
opsy. Pathological analysis of the ureteral stricture side 
showed metastatic carcinoma invasion. Additionally, CT 
revealed an infiltrative mass in the left upper retroperi-
toneum with adhesion of the left upper ureter. 
Subsequently, the patient developed malignant ascites 
with carcinomatosis and died of a suspected pulmonary 
embolism 7 months after the operation.
3.  Discussion
Hematuria is frequently the main symptom of a bladder 
tumor. A series of investigations including urine cytol-
ogy, imaging studies, or even cystoscopic biopsy should 
be undertaken. Urachal cancer should be considered for 
a bladder dome tumor, especially if associated with bloody 
or mucoid discharge from the umbilicus or a palpable 
mucocele. Patients with primary gastric cancer should be 
evaluated under the suspicion of bladder metastasis and 
investigated accordingly. Generally, the most common 
tumors metastasizing to the bladder are melanomas, fol-
lowed by breast cancers and gastric adenocarcinomas.2
epithelium (Figure 1B). A whole-body bone scan demon-
strated metastatic lesions in the sacrum and the sixth rib 
on the right side. Systemic chemotherapy (with fluoro-
uracil, epirubicin, and carboplatin) was administered. 
Because of persistent left hydronephrosis caused by a 
single upper ureteral stricture (Figure 4), the patient 
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The management of metastatic bladder cancer is 
usually complex. It is important to distinguish a primary 
bladder adenocarcinoma from metastatic cancers be-
cause the treatment strategies for the two entities are 
very different. For patients with primary bladder cancer, 
a radical cystectomy usually provides a good prognosis. 
On the other hand, surgical treatment plays a limited 
role in treating metastatic bladder cancer, with chemo-
therapy or radiotherapy providing some benefit. In this 
case, the tumor had spread to the bladder and the left 
urinary tract. A pathological examination confirmed the 
diagnosis of a bladder metastatic adenocarcinoma, and 
a biopsy sample of the left ureter showed tumor inva-
sion. Although courses of chemotherapy were adminis-
tered, the response rate was poor. Eventually, the patient 
died of a pulmonary embolism 7 months after the partial 
cystectomy.
Metastasis to the urinary bladder usually develops 
many years after the diagnosis of a primary cancer 
(mean, 7 years).2 Urinary symptoms are infrequent in 
cases of secondary bladder cancer, unlike cases with pri-
mary bladder malignancy. Only 3 of 21 bladder metasta-
sis cases reported by Sheehan et al. were symptomatic.2 
Similarly, Klinger et al. reported that 27 of 142 cases of 
urogenital tract metastasis had urinary symptoms.2 It is 
difficult to determine whether bladder metastasis exists 
in clinical practice. However, once urinary symptoms de-
velop in a patient who has malignant disease, bladder 
involvement should be highly suspected. CT and mag-
netic resonance imaging are useful techniques for diag-
nosing bladder cancers. Metastatic lesions are usually 
solitary with focal thickening of the bladder wall but 
sometimes show diffuse thickening of the wall.3 
Ultrasonography is more useful for evaluating upper uri-
nary tract function and obstruction. Generally, it is difficult 
to distinguish between primary bladder adenocarcinoma 
and metastatic adenocarcinoma solely on the basis of 
the histological findings. A metastatic tumor should be 
suspected if the tumor extends from the bladder serosa 
to the mucosa, especially in cases with a history of 
tumor origin from another site. In our case, the bladder 
tumor was pathologically determined to be a poorly dif-
ferentiated adenocarcinoma with glandular cell infiltration 
and intact urothelial epithelium, which was consistent 
with the diagnosis of metastatic cancer. Fornage et al. 
reported a case of bladder wall metastasis from stom-
ach cancer that was diagnosed by abdominal and pelvic 
sonography.4 In patients with hematuria or lower-urinary-
tract symptoms, cystoscopy is mandatory for tumor di-
agnosis, as performed in our case. Furthermore, almost 
all cases of bladder metastasis from gastric cancer have 
peritoneal dissemination; therefore, the prognosis in such 
cases is very poor.5 Generally, treatment with curative 
intention is impossible because of the metastatic nature 
of the disease, and adjuvant chemotherapy is indicated, 
although its results are not entirely satisfactory.6 Apart 
from the bladder, the ureter is another less common site 
for metastases of a gastric malignancy, which result in 
severe but rare complications such as acute disseminated 
intravascular coagulation.7
In conclusion, the bladder is an uncommon site for 
distant cancer metastasis. The presence of bladder ade-
nocarcinoma should raise the suspicion of a primary 
cancer focus at some other site. For patients in whom 
the primary cancer site is known and urinary tract symp-
toms are present, cystoscopy or an upper-urinary-tract 
investigation is necessary. In general, the survival rate in 
such cases is poor, and the clinical course is aggressive in 
patients with bladder metastasis.
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